Cargando…

Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants

As cutaneous melanoma (CM) currently remains with a bleak prognosis, thorough investigation of new treatment options are of utmost relevance. In the phase II/III randomized clinical trial (CASVAC-0401), the repeated immunization of stages IIB-III CM patients with the irradiated, allogeneic cellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pampena, María B., Cartar, Holliday C., Cueto, Gerardo Rubén, Levy, Estrella M., Blanco, Paula A., Barrio, María M., Mordoh, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224428/ https://www.ncbi.nlm.nih.gov/pubmed/30450100 http://dx.doi.org/10.3389/fimmu.2018.02531

Ejemplares similares

Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release
por: Pampena, María B., et al.
Publicado: (2017)

Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report
por: Aris, Mariana, et al.
Publicado: (2018)

Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette–Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study
por: Mordoh, José, et al.
Publicado: (2017)

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
por: Aris, Mariana, et al.
Publicado: (2019)

Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF
por: Podaza, Enrique, et al.
Publicado: (2020)

Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
por: Juliá, Estefanía Paula, et al.
Publicado: (2018)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases
por: Mordoh, Ana, et al.
Publicado: (2022)

Hormesis in cancer immunology: Does the quantity of an immune reactant matter?
por: Pearce, Oliver MT, et al.
Publicado: (2014)

Natural Killer Cells as Helper Cells in Dendritic Cell Cancer Vaccines
por: Pampena, María Betina, et al.
Publicado: (2015)

A SYNTHETIC ADJUVANT EFFECTIVE IN INDUCING ANTITUMOR IMMUNITY
por: Kataoka, Tetsuro, et al.
Publicado: (1988)

Amdahl 470 Chip Package
Publicado: (1975)

Alterations of Innate Immunity Reactants in Transition Dairy Cows before Clinical Signs of Lameness
por: Zhang, Guanshi, et al.
Publicado: (2015)

Natural Killer Cells in Human Cancer: From Biological Functions to Clinical Applications
por: Levy, Estrella Mariel, et al.
Publicado: (2011)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

Séminaire Bourbaki : exposés 453–470
por: Collective
Publicado: (1976)

Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity
por: de Gruil, Nadia, et al.
Publicado: (2022)

Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
por: Lee, Katherine S, et al.
Publicado: (2023)

IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants
por: Freire, P.C., et al.
Publicado: (2017)

SAT-470 When The Heart Can’t Clap To The Thyroid’s Beat
por: Thakkar, Aditi, et al.
Publicado: (2020)

MON-470 Biotin Masquerading as Subclinical Hyperthyroidism
por: Eapen, Anita, et al.
Publicado: (2020)

Acute Phase Reactants: Relevance in Dermatology
por: Jishna, Pulpadathil, et al.
Publicado: (2022)

Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2015)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
por: Loo, Kimberly, et al.
Publicado: (2022)

Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15
por: Rocca, Yamila Sol, et al.
Publicado: (2016)

Re‐evaluation of sodium, potassium and calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) as food additives
por: Younes, Maged, et al.
Publicado: (2018)

Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer
por: Juliá, Estefanía Paula, et al.
Publicado: (2020)

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
por: von Euw, Erika M, et al.
Publicado: (2008)

Norcantharidin enhances antitumor immunity of GM‐CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells
por: Mo, Lijun, et al.
Publicado: (2018)

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity
Publicado: (1996)

Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma
por: Meng, Gang, et al.
Publicado: (2019)

Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia.
por: Nishimura, Y., et al.
Publicado: (1996)

Immunologic reactants in the pathogenesis of atherosclerosis in rheumatic diseases
por: Cronstein, B, et al.
Publicado: (2003)

Enhanced Reactant Distribution in Redox Flow Cells
por: Gurieff, Nicholas, et al.
Publicado: (2019)

Types of acute phase reactants and their importance in vaccination
por: Khalil, Rafaat H., et al.
Publicado: (2020)

Long-Term Antitumor CD8(+) T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

Long-term protective immunity induced by an adjuvant-containing live-attenuated AIDS virus
por: Okamura, Tomotaka, et al.
Publicado: (2021)

Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
por: Deng, Caifeng, et al.
Publicado: (2019)

Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice
por: Roberti, María Paula, et al.
Publicado: (2012)

Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
por: Yan, Wan-Lun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5omnjm8qfik13ct9t506ctkpaq